Earlier in January, the company received the Establishment Inspection Report (EIR) from USFDA for its Pithampur Unit-1 ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...

Lupin: Pharmaceutical company Lupin received an Establishment Inspection Report (EIR) from the US FDA for its Pithampur Unit-1 facility, which manufactures APIs and finished products. The EIR ...

Lupin, a global pharmaceutical company, announced that it has received a Voluntary Action Indicated (VAI) classification from the United States Food and Drug Administration (US FDA) for its Pithampur ...

Share of Mumbai-based pharmaceutical major Lupin Limited shares surged as much as 1.79% to reach ₹2,292.90 apiece on the BSE after receiving an Establishment Inspection Report (EIR) from the US Food ...

Nilesh Gupta, MD, Lupin said, We are pleased to receive the EIR from the US FDA for our Pithampur Unit-1 facility with a satisfactory ... Mumbai-based Lupin is an innovation-led transnational ...